Ilika moves closer to commercialising its large‑format solid‑state batteries

Ilika Plc

The recent progress at Ilika points to a company actively positioning itself for commercial relevance in the electric vehicle supply chain. While many solid‑state battery concepts remain stuck in the lab, Ilika’s Goliath programme is beginning to show the kind of practical advances that matter to OEMs and long‑term investors alike.

The Goliath programme focuses on developing large‑format pouch cells using solid‑state technology built around a solid ceramic electrolyte and a high‑energy silicon anode. This combination allows for improved thermal stability, greater energy density, and potentially faster charging.

In April 2025, Ilika confirmed that cells manufactured using production‑grade equipment at the UK Battery Industrialisation Centre achieved higher yields and faster charge performance than earlier prototypes. It means the company is now working with equipment and processes that mirror commercial settings, rather than relying on lab tools. As part of its roadmap, Ilika is building a 1.5 MWh pre‑commercial production line, which will supply evaluation cells to automotive partners and Tier 1 suppliers.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search